In this episode, we explore the growing popularity and science behind GLP-1 receptor agonists like semaglutide (Ozempic®, Wegovy®), medications initially developed for type 2 diabetes that have become game-changers in weight loss management. We’ll examine how these drugs work to regulate appetite, slow gastric emptying, and promote fat loss while discussing their effectiveness compared to traditional approaches. With soaring prescription rates and celebrity endorsements, GLP-1 agonists have gained attention for their transformative potential in combating obesity, a chronic condition affecting millions.

Listeners will learn about the benefits, side effects, and myths surrounding these medications, as well as the economic and accessibility challenges that patients face. We’ll also highlight the importance of combining these treatments with healthy lifestyle changes to achieve sustainable weight loss. Whether you’re curious about the science or considering options for weight management, this episode delivers a comprehensive overview for the lay audience.